KH

Kersi Homi Tangri

Active Director Director DIN 01215877
DIN 01215877 First appointment Jul 2006 Primary industry Manufacturing
Unlock full profile Investments · shareholding · contact details
Current companies 6 active board seats
Past companies 2 historical roles
Total affiliations 8 Since Jul 2006
Shareholding value •••• Premium profile

About Kersi Homi Tangri

Data last updated:

Kersi Homi Tangri is a Director at Avesta Pharma Private Limited (since 2009), Whole-Time Director at Biesterfeld Hildose Speciality Chemicals Private Limited (since 2023) and Director at Accusynth Speciality Chemicals Private Limited (since 2006), and holds 3 more current directorships. The companies operate in Manufacturing, Chemicals and Materials and Household Services. The 4 current companies with reported revenue have a combined latest revenue of ₹281 Cr; the largest is Avesta Pharma Private Limited at ₹202 Cr (FY 2025). Earlier, Kersi Homi Tangri was a Director at Dyna Glycols Private Limited (2006–2018) and Director at Hildose Pharma Private Limited (2012–2020).

DIN 01215877
Primary Designation Director
Industry Manufacturing
First Appointment 27 Jul 2006
Oldest Company Age 48 yrs
Largest company Avesta Pharma Private Limited · ₹202 Cr (FY 2025)
Combined revenue ₹281 Cr across 4 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Avesta Pharma Private Limited U24239MH2009PTC192677
Director25 May 20092009₹202 Cr (FY 2025)Active
Whole-Time Director17 Nov 20232023₹53.44 Cr (FY 2025)Active
Director27 Jul 20061979₹24.90 Cr (FY 2020)Active
Firoze Estates Private Limited U45200MH1978PTC020141
Director05 Aug 20101978₹22.8 Lakh (FY 2025)Active
Designated Partner12 Feb 20202020Active
Director10 Jun 20082008Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Dyna Glycols Private Limited U24119MH2006PTC164262
Director01 Sep 20062006₹303 Cr (FY 2024)Active
Hildose Pharma Private Limited U24233MH2012PTC239076
Director24 Dec 20122012Converted To Llp

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Hildose Pharmaspecialities Llp
Accusynth Speciality Chemicals Private Limited
Avesta Pharma Private Limited
Firoze Estates Private Limited
Premium access

Shareholding and investment profile for Kersi Homi Tangri

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kersi Homi Tangri

Kersi Homi Tangri currently holds 6 directorships: Avesta Pharma Private Limited (Director, since 25 May 2009, revenue ₹202 Cr (FY 2025)); Biesterfeld Hildose Speciality Chemicals Private Limited (Whole-Time Director, since 17 Nov 2023, revenue ₹53.44 Cr (FY 2025)); Accusynth Speciality Chemicals Private Limited (Director, since 27 Jul 2006, revenue ₹24.90 Cr (FY 2020)); Firoze Estates Private Limited (Director, since 05 Aug 2010, revenue ₹22.8 Lakh (FY 2025)); Hildose Pharmaspecialities Llp (Designated Partner, since 12 Feb 2020); and 1 more.

Kersi Homi Tangri was first appointed on 27 Jul 2006 as Director at Accusynth Speciality Chemicals Private Limited. The most recent appointment on record is 17 Nov 2023 at Biesterfeld Hildose Speciality Chemicals Private Limited.

The 4 current companies of Kersi Homi Tangri that report revenue have a combined latest revenue of ₹281 Cr: Avesta Pharma Private Limited ₹202 Cr (FY 2025); Biesterfeld Hildose Speciality Chemicals Private Limited ₹53.44 Cr (FY 2025); Accusynth Speciality Chemicals Private Limited ₹24.90 Cr (FY 2020); Firoze Estates Private Limited ₹22.8 Lakh (FY 2025).

Kersi Homi Tangri held 2 earlier board appointments: Dyna Glycols Private Limited (Director, 01 Sep 2006 to 02 Jun 2018); Hildose Pharma Private Limited (Director, 24 Dec 2012 to 11 Feb 2020).

The current boards of Kersi Homi Tangri's companies include Amol Ashok Walke (Avesta Pharma Private Limited), Eric Kersi Tangri (Avesta Pharma Private Limited), Mahesh Hakmichand Doshi (Avesta Pharma Private Limited), Zubin Keki Gandhi (Avesta Pharma Private Limited), Andreas Wilhelm Lekebusch (Biesterfeld Hildose Speciality Chemicals Private Limited), Bettina Heick (Biesterfeld Hildose Speciality Chemicals Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available